 |
|
|
| |
Changes in cognitive function over 96 weeks after initiating darunavir/ritonavir with either raltegravir or tenofovir-emtricitabine; NEAT 001 / ANRS 143 randomised controlled study
|
| |
| |
Reported by Jules Levin
EACS 2015 Oct 21-24 Barcelona, Spain -15th European AIDS Conference
Alan Winston, Wolfgang Stöhr, Andrea Antinori, Helene Amieva, Philippe Perré, Stephane De Wit, Jacques Reynes, Mark Gompels, Antonella d'Arminio Monforte, Jose-Maria Gatell, Anton Pozniak, Abdel Babiker, François Raffi and Laura Richert for the NEAT 001/ANRS 143 Study Group
|
| |
|
|
|
|
|
